Literature DB >> 11080676

Structure, function, and regulation of group V phospholipase A(2).

W Cho1.   

Abstract

The hydrolysis of membrane phospholipid by phospholipase A(2) (PLA(2)) is a key step in the production of inflammatory eicosanoids. Recent cell studies have shown that secretory group V PLA(2) (gVPLA(2)) is involved in agonist-induced eicosanoid biosynthesis in mouse P388D1 cell line, mast cells, and transfected HEK 293 cells. gVPLA(2) is homologous to other group II PLA(2) family members but has distinctive enzymatic properties, including its activity to effectively hydrolyze phosphatidylcholine (PC) vesicles and the outer plasma membrane of mammalian cells. Mutational studies showed that gVPLA(2) has a unique structure that allows effective binding to PC membranes and efficient catalysis of an active-site-bound PC substrate. Thanks to this unique structure and activity, exogenously added gVPLA(2) can induce the eicosanoid biosynthesis in unstimulated inflammatory cells, including human neutrophils and eosinophils, suggesting that it might be able to trigger inflammatory responses under certain physiological conditions. Extensive structure-function and cell studies showed that gVPLA(2) could act directly on the outer plasma membranes of neutrophils and eosinophils. The release of fatty acids and lysophospholipids from the cell surfaces induces the translocation and activation of cytosolic PLA(2) and 5-lipoxygenase, resulting in the leukotriene synthesis. In case of neutrophils, induction of leukotriene B(4) synthesis by gVPLA(2) leads to the phosphorylation of cytosolic PLA(2) by a leukotriene B(4) receptor and MAP kinase-mediated mechanism. Finally, heparan sulfate proteoglycans in neutrophils appear to play a role of internalizing and degrading the cell surface-bound gVPLA(2) to protect the cells from extensive lipolytic damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080676     DOI: 10.1016/s1388-1981(00)00109-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2.

Authors:  Dev K Singh; Laurence R Gesquiere; Papasani V Subbaiah
Journal:  Arch Biochem Biophys       Date:  2006-11-21       Impact factor: 4.013

Review 2.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Authors:  Nhat D Quach; Robert D Arnold; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2014-06-04       Impact factor: 5.858

Review 3.  Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Authors:  Gianfrancesco Goracci; Monica Ferrini; Vincenza Nardicchi
Journal:  Mol Neurobiol       Date:  2010-03-19       Impact factor: 5.590

4.  VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.

Authors:  P N Bernatchez; M V Winstead; E A Dennis; M G Sirois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2.

Authors:  Chang-Zhi Dong; Anthony Romieu; Carine M Mounier; Françoise Heymans; Bernard P Roques; Jean-Jacques Godfroid
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

Review 6.  Role of secretory phospholipases in atherogenesis.

Authors:  Ann-Cathrine Jönsson-Rylander; Sofia Lundin; Birgitta Rosengren; Camilla Pettersson; Eva Hurt-Camejo
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

7.  Relationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis.

Authors:  Rachel W Bailey; Erin D Olson; Mai P Vu; Taylor J Brueseke; Leslie Robertson; Ryan E Christensen; Kristen H Parker; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

8.  Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice.

Authors:  K G Schraut; S B Jakob; M T Weidner; A G Schmitt; C J Scholz; T Strekalova; N El Hajj; L M T Eijssen; K Domschke; A Reif; T Haaf; G Ortega; H W M Steinbusch; K P Lesch; D L Van den Hove
Journal:  Transl Psychiatry       Date:  2014-10-21       Impact factor: 6.222

9.  Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils.

Authors:  Stefania Loffredo; Francesco Borriello; Raffaella Iannone; Anne L Ferrara; Maria R Galdiero; Vincenzo Gigantino; Pasquale Esposito; Gilda Varricchi; Gerard Lambeau; Marco A Cassatella; Francescopaolo Granata; Gianni Marone
Journal:  Front Immunol       Date:  2017-04-19       Impact factor: 7.561

10.  Group V Secretory Phospholipase A2 Is Involved in Tubular Integrity and Sodium Handling in the Kidney.

Authors:  João Luiz Silva-Filho; Diogo Barros Peruchetti; Felipe Moraes-Santos; Sharon Schilling Landgraf; Leandro Souza Silva; Gabriela Modenesi Sirtoli; Daniel Zamith-Miranda; Christina Maeda Takiya; Ana Acacia Sá Pinheiro; Bruno Lourenço Diaz; Celso Caruso-Neves
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.